{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:33:59Z","timestamp":1761647639164},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"872","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,6,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.<\/jats:p>","DOI":"10.1136\/pgmj.74.872.363","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:49:00Z","timestamp":1230587340000},"page":"363-364","source":"Crossref","is-referenced-by-count":11,"title":["Further hearing loss during osteoporosis treatment with etidronate"],"prefix":"10.1093","volume":"74","author":[{"given":"S","family":"Ya\u015fil","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Dokuz Eyl\u00fcl University, Medical Faculty , Inciralti, \u0130zmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"\u00c7\u00f6mlek\u00e7i","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Dokuz Eyl\u00fcl University, Medical Faculty , Inciralti, \u0130zmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"G\u00fcneri","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Division of Endocrinology and Metabolism, Dokuz Eyl\u00fcl University, Medical Faculty , Inciralti, \u0130zmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1998,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.309.6956.711","article-title":"The therapeutic use of bisphosphonates","volume":"309","author":"Compston, J.E.","year":"1994","unstructured":"Compston JE. The therapeutic use of bisphosphonates. BMJ 1994;309:711-5.","journal-title":"BMJ"},{"key":"ref_2","first-page":"99","article-title":"Etiology of otospongiotic sensorineural hearing loss","volume":"10","author":"Causse, JR, Causse; JB, Bretlau; P.","year":"1989","unstructured":"Causse JR, Causse JB, Bretlau P, et al. Etiology of otospongiotic sensorineural hearing loss. Am J Otol 1989;10:99-107.","journal-title":"Am J Otol"},{"key":"ref_3","first-page":"343","article-title":"Otosclerotic involvement ofthe cochlea: a Neck Surg histologic and audiologic","volume":"89","author":"Elonka, D.R.; Applebaum, E.L.","year":"1981","unstructured":"Elonka DR, Applebaum EL. Otosclerotic involvement ofthe cochlea: a Neck Surg histologic and audiologic 1981;89:343-51."},{"key":"ref_4","first-page":"461","article-title":"The effects of etidronate disodium on progressive hearing loss from otosclerosis","volume-title":"Otolaryngol Head Neck Surg","volume":"109","author":"Kennedy, D.W.","year":"1993","unstructured":"Kennedy DW. The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg 1993;109:461-7."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-979008","article-title":"Bisphosphonates: mechanisms of action and clinical use in osteoporosis-an update","volume":"29","author":"Fleisch, H.","year":"1997","unstructured":"Fleisch H. Bisphosphonates: mechanisms of action and clinical use in osteoporosis-an update. Horm Metab Res 1997;29:145-50.","journal-title":"Horm Metab Res"},{"key":"ref_6","first-page":"100","article-title":"Clearence and tissue uptake nate in following 4-hour rats. Drug Metab and 24-hour infusions Dispos","volume":"21","author":"Pongchaidecha, M.; Daleyyates, P.T.","year":"1993","unstructured":"Pongchaidecha M, Daleyyates PT. Clearence and tissue uptake nate in following 4-hour rats. Drug Metab and 24-hour infusions Dispos 1993;21:100-4."}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/872\/363\/50222011\/postgradmedj-74-363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/872\/363\/50222011\/postgradmedj-74-363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:40:07Z","timestamp":1683898807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/74\/872\/363\/7059785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6,1]]},"references-count":6,"journal-issue":{"issue":"872","published-online":{"date-parts":[[1998,6,1]]},"published-print":{"date-parts":[[1998,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.74.872.363","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,6]]},"published":{"date-parts":[[1998,6,1]]}}}